OBJECTIVES: Prostate specific antigen (PSA) testing as a part of a prostate cancer control strategy is the subject of much debate. This paper examines variations in the uptake of PSA testing across Europe and the role of individual and contextual variables in explaining this variation. METHODS: Data were taken from Eurobarometer 66.2 "Health in the European Union" 2006 on self-reported uptake of screening. Data related to men across the EU-27 and Croatia, aged 40 and over (N=6986). A logistic regression analysis examines the role of individual characteristics across and within the countries. RESULTS: A range of individual characteristics were found to be statistically significant predictors of uptake including education, marital status, and smoking status. Socio-economic status (SES) was also a statistically significant predictor of the likelihood of screening. Variation across countries in uptake was evident; importantly a significant role was accorded primary care in explaining variation in uptake. CONCLUSION: Uptake of PSA testing varies considerably within and across European countries. Differences within states relate to the characteristics of individuals offered tests and differences between states, to the system of primary care in operation. Given the significant welfare losses implicit in the evident variations the role of primary care warrants further investigation.
OBJECTIVES:Prostate specific antigen (PSA) testing as a part of a prostate cancer control strategy is the subject of much debate. This paper examines variations in the uptake of PSA testing across Europe and the role of individual and contextual variables in explaining this variation. METHODS: Data were taken from Eurobarometer 66.2 "Health in the European Union" 2006 on self-reported uptake of screening. Data related to men across the EU-27 and Croatia, aged 40 and over (N=6986). A logistic regression analysis examines the role of individual characteristics across and within the countries. RESULTS: A range of individual characteristics were found to be statistically significant predictors of uptake including education, marital status, and smoking status. Socio-economic status (SES) was also a statistically significant predictor of the likelihood of screening. Variation across countries in uptake was evident; importantly a significant role was accorded primary care in explaining variation in uptake. CONCLUSION: Uptake of PSA testing varies considerably within and across European countries. Differences within states relate to the characteristics of individuals offered tests and differences between states, to the system of primary care in operation. Given the significant welfare losses implicit in the evident variations the role of primary care warrants further investigation.
Authors: Zachary Klaassen; Christopher J D Wallis; Hanan Goldberg; Thenappan Chandrasekar; Neil E Fleshner; Antonio Finelli; Girish S Kulkarni; Allan S Detsky; Raj Satkunasivam Journal: Can Urol Assoc J Date: 2018-06-19 Impact factor: 1.862
Authors: Paul Nderitu; Mieke Van Hemelrijck; Mark Ashworth; Rohini Mathur; Sally Hull; Alexandra Dudek; Simon Chowdhury Journal: BMJ Open Date: 2016-07-12 Impact factor: 2.692
Authors: Folkert de Groot; Stefano Capri; Jean-Claude Castanier; David Cunningham; Bruno Flamion; Mathias Flume; Harald Herholz; Lars-Åke Levin; Oriol Solà-Morales; Christoph J Rupprecht; Natalie Shalet; Andrew Walker; Olivier Wong Journal: Appl Health Econ Health Policy Date: 2017-04 Impact factor: 2.561
Authors: Richéal M Burns; Linda Sharp; Francis J Sullivan; Sandra E Deady; Frances J Drummond; Ciaran O Neill Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240
Authors: Andrzej Prajsner; Jerzy Chudek; Aleksandra Szybalska; Karolina Piotrowicz; Jan Zejda; Andrzej Więcek Journal: Arch Med Sci Date: 2016-06-06 Impact factor: 3.318
Authors: Jorma Sormunen; Madar Talibov; Pär Sparén; Jan Ivar Martinsen; Elisabete Weiderpass; Eero Pukkala Journal: Asian Pac J Cancer Prev Date: 2018-08-24